The B-Cure Laser, a low-level laser therapy (LLLT) system that allows chronic pain sufferers to alleviate their pain, has been released in the United Kingdom.
The mobile, compact, non-invasive LLLT system has benefited people suffering from chronic pain across North America, Europe, and Asia, with 76 percent of B-Cure Laser users no longer suffering from unbearable pain.
More than 250,000 devices have been sold worldwide, and with 28 million people in the United Kingdom suffering from chronic pain, the system would provide an at-home treatment choice.
Chronic pain incidence increases gradually with age, affecting up to 62 percent of the population aged 75 and over, according to a study conducted in the UK by Dr. Alan Fayaz. According to the survey, 14.2 percent (7.9 million people) of the population may be moderately or seriously limited by pain.
B-Cure Laser’s UK Boss, Itay Avni, said: “Chronic pain is a historic curse for which we now have a technologically advanced remedy.” Our laser therapy is changing the way chronic pain is treated. The user will take better care of themselves and their families by treating pain at home with our system. Lower and upper back pain, knee and neck pain, carpal tunnel syndrome, and other conditions that are usually often treated in medical facilities can all be treated with the B-Cure Laser.
“More than 250,000 people have benefitted from our devices globally, and we are thrilled to be widening its availability to people across the UK.”
The product has undergone several clinical trials. The University of Parma’s Department of Biomedical, Biotechnological, and Translational Sciences conducted a B-Cure Laser pilot study, which showed that the study group’s pain levels were substantially reduced after laser treatment. The group had an average pain rating score of 6 at the start of the study on a zero to ten scale, with zero being no pain and ten being intolerable pain. One week after treatment, the group’s score dropped to 2.92 on the scale and 2.58 after two weeks.
Ninety people were divided into three classes in a subsequent analysis at the University of Rome. One group was given the B-Cure Laser, another was given opioids, and a third was given a B-Cure Laser that looked like the real thing but didn’t have a beam.
The findings showed that those who took opioids and those who used the B-Cure Laser reported the same pain relief, with the B-Cure Laser having the advantage of having no harmful effects on the organs.
Dr. David Ben Kiki, an Israeli chiropractor with 37 years of experience, is pleased to see B-Cure enter the UK laser treatment market.
He said: “I remember when a laser took up a whole room, a person needed to be on a bed, and everyone else needed to leave the room. The results I’ve got for people with sprains, knee injuries, low back pain, sacroiliitis, and TMJ syndrome have been excellent.
“I had a patient come in a few weeks ago with extreme low back pain, especially in the sacroiliac joint. Much of the chiropractic work I did with her helped, but the one thing she came in for wasn’t freeing. During that six-minute visit with her, I used the B-Cure Laser. ‘It feels like Novocain was injected into the joint; it’s numb, I don’t feel it, I have no pain,’ she said as she stood up from the table.
“She bought the B-Cure Laser and has been using it religiously every day, and she’s living without pain.”
